PHILADELPHIA (WPVI) -- It's the only authorized treatment that can help keep people with COVID-19 out of the hospital, but hundreds-of-thousands of doses aren't being used. The effectiveness of ...

U.S. Navy Petty Officer 3rd Class Andre May, a Sailor with Expeditionary Medical Facility-M and a native of Mount Vernon, N.Y., checks a patient’s blood pressure at Baton Rouge General Mid City campus ...

Monoclonal antibody treatments are saving lives from COVID-19 and helps keep patients out of Triangle hospitals. Doctors are infusing newly diagnosed COVID-19 patients with antibodies that have been ...

The Biden administration last week called on health care providers once more to use monoclonal antibody treatments on those at high risk of suffering severe illness from the COVID-19 virus. The drug, ...

The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...

NEW YORK (WABC) -- Federal regulators are considering limiting the authorization of certain monoclonal antibody treatments that have not proved effective against the omicron variant of the coronavirus ...

New research from Cedars-Sinai's Comprehensive Transplant Center found that a monoclonal antibody treatment reduced the risk of COVID-19 in a large group of solid organ transplant patients who were ...

While doctors have stressed the importance of COVID-19 vaccinations, there are also coronavirus treatments helping sick patients stay out of the hospital. Monoclonal antibody therapy is gaining ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. New data from phase 3 trials of monoclonal antibodies for patients with recent COVID-19 diagnoses, ...

The US government is buying more doses of monoclonal antibody treatments for Covid-19, and the Biden administration is taking over distribution in order to avoid shortages of the key therapeutics. The ...

If you’re older than 12 and test positive for COVID-19, you most likely qualify to receive monoclonal antibody treatment on Texas’ dime. For most, the largest barrier to getting the early-stage ...